keyword
https://read.qxmd.com/read/38606009/-in-vivo-bistatic-dual-aperture-ultrasound-imaging-and-elastography-of-the-abdominal-aorta
#1
JOURNAL ARTICLE
Vera H J van Hal, Hein de Hoop, Marc R H M van Sambeek, Hans-Martin Schwab, Richard G P Lopata
Introduction: In this paper we introduce in vivo multi-aperture ultrasound imaging and elastography of the abdominal aorta. Monitoring of the geometry and growth of abdominal aortic aneurysms (AAA) is paramount for risk stratification and intervention planning. However, such an assessment is limited by the lateral lumen-wall contrast and resolution of conventional ultrasound. Here, an in vivo dual-aperture bistatic imaging approach is shown to improve abdominal ultrasound and strain imaging quality significantly...
2024: Frontiers in Physiology
https://read.qxmd.com/read/38502052/marizomib-for-patients-with-newly-diagnosed-glioblastoma-a-randomized-phase-3-trial
#2
JOURNAL ARTICLE
Patrick Roth, Thierry Gorlia, Jaap C Reijneveld, Filip de Vos, Ahmed Idbaih, Jean-Sébastien Frenel, Emilie Le Rhun, Juan Manuel Sepulveda, James Perry, G Laura Masucci, Pierre Freres, Hal Hirte, Clemens Seidel, Annemiek Walenkamp, Slavka Lukacova, Paul Meijnders, Andre Blais, Francois Ducray, Vincent Verschaeve, Garth Nicholas, Carmen Balana, Daniela A Bota, Matthias Preusser, Sarah Nuyens, Fréderic Dhermain, Martin van den Bent, Chris J O'Callaghan, Maureen Vanlancker, Warren Mason, Michael Weller
BACKGROUND: Standard treatment for patients with newly diagnosed glioblastoma includes surgery, radiotherapy (RT) and temozolomide (TMZ) chemotherapy (TMZ/RT→TMZ). The proteasome has long been considered a promising therapeutic target because of its role as a central biological hub in tumor cells. Marizomib is a novel pan-proteasome inhibitor that crosses the blood brain barrier. METHODS: EORTC 1709/CCTG CE.8 was a multicenter, randomized, controlled, open label phase 3 superiority trial...
March 19, 2024: Neuro-oncology
https://read.qxmd.com/read/38361199/tumeszenz-lokalan%C3%A3-sthesie-bei-geriatrischen-patienten-mit-hauttumoren-im-kopf-hals-bereich-eine-retrospektive-studie-an-782-patienten-tumescent-local-anesthesia-in-geriatric-patients-with-head-and-neck-skin-cancer-a-retrospective-study-of-782-patients
#3
JOURNAL ARTICLE
Saskia Maria Schnabl, Claus Garbe, Helmut Breuninger, Vincent Walter, Valentin Aebischer, Julia Huynh, Franziska Carola Ghoreschi, Hans-Martin Häfner, Alexander Scheu
No abstract text is available yet for this article.
February 2024: Journal der Deutschen Dermatologischen Gesellschaft: JDDG
https://read.qxmd.com/read/38353674/-virtual-degum-certified-course-in-the-head-and-neck-region-a-useful-complement-to-conventional-course-formats
#4
JOURNAL ARTICLE
Gabriel Hillebrand, Martin Gartmeier, Nora Weiss, Luca Engelmann, Anna Stenzl, Felix Johnson, Benedikt Hofauer
BACKGROUND: Training in clinical ultrasound has become highly relevant for working as an otorhinolaryngologist. While there is a high demand for standardized and certified training courses, until recently, there was no possibility to attend web-based and exclusively virtual head and neck ultrasound courses certified by the Deutsche Gesellschaft für Ultraschall in der Medizin (DEGUM; German Society for Ultrasound in Medicine). OBJECTIVE: The aim of this study was to provide a qualitative and semi-quantitative analysis of the first purely virtual DEGUM-certified head and neck ultrasound courses...
February 14, 2024: HNO
https://read.qxmd.com/read/38349226/switch-to-bictegravir-emtricitabine-tenofovir-alafenamide-from-dolutegravir-based-therapy-96-week-pooled-analysis
#5
JOURNAL ARTICLE
Chloe Orkin, Andrea Antinori, Jürgen K Rockstroh, Santiago Moreno-Guillén, Claudia T Martorell, Jean-Michel Molina, Adriano Lazzarin, Franco Maggiolo, Yazdan Yazdanpanah, Kristen Andreatta, Hailin Huang, Jason T Hindman, Hal Martin, Anton Pozniak
OBJECTIVE: To evaluate the efficacy and safety of 96 weeks of bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) treatment in participants switching from dolutegravir (DTG)-based therapy. DESIGN: Studies 1489 (NCT02607930) and 1490 (NCT02607956) were phase 3 randomized, double-blind, active-controlled, first-line therapy trials in people with HIV-1. After 144 weeks of DTG-based or B/F/TAF treatment, participants could enter a 96-week open-label extension (OLE) of B/F/TAF...
February 12, 2024: AIDS
https://read.qxmd.com/read/38212081/two-duckweed-species-exhibit-variable-tolerance-to-microcystin-lr-exposure-across-genotypic-lineages
#6
JOURNAL ARTICLE
Lacey D Rzodkiewicz, Martin M Turcotte
Cyanotoxins produced by harmful cyanobacteria blooms can damage freshwater ecosystems and threaten human health. Floating macrophytes may be used as a means of biocontrol by limiting light and resources available to cyanobacteria. However, genetic variation in macrophyte sensitivity to cyanotoxins could influence their suitability as biocontrol agents. We investigated the influence of such intraspecific variation on the response of two rapidly growing duckweed species, Lemna minor and Spirodela polyrhiza, often used in nutrient and metal bioremediation...
January 2024: Harmful Algae
https://read.qxmd.com/read/37951605/microcystin-aids-in-cold-temperature-acclimation-differences-between-a-toxic-microcystis-wildtype-and-non-toxic-mutant
#7
JOURNAL ARTICLE
Gwendolyn F Stark, Robbie M Martin, Laura E Smith, Bofan Wei, Ferdi L Hellweger, George S Bullerjahn, R Michael L McKay, Gregory L Boyer, Steven W Wilhelm
For Microcystis aeruginosa PCC 7806, temperature decreases from 26 °C to 19 °C double the microcystin quota per cell during growth in continuous culture. Here we tested whether this increase in microcystin provided M. aeruginosa PCC 7806 with a fitness advantage during colder-temperature growth by comparing cell concentration, cellular physiology, reactive oxygen species damage, and the transcriptomics-inferred metabolism to a non-toxigenic mutant strain M. aeruginosa PCC 7806 ΔmcyB...
November 2023: Harmful Algae
https://read.qxmd.com/read/37883517/hedges-mottes-and-baileys-causally-ambiguous-statistical-language-can-increase-perceived-study-quality-and-policy-relevance
#8
JOURNAL ARTICLE
Daniela Alvarez-Vargas, David Braithwaite, Hugues Lortie-Forgues, Melody Moore, Sirui Wan, Elizabeth Martin, Drew Hal Bailey
There is a norm in psychology to use causally ambiguous statistical language, rather than straightforward causal language, when describing methods and results of nonexperimental studies. However, causally ambiguous language may inhibit a critical examination of the study's causal assumptions and lead to a greater acceptance of policy recommendations that rely on causal interpretations of nonexperimental findings. In a preregistered experiment, 142 psychology faculty, postdocs, and doctoral students (54% female), ages 22-67 (M = 33...
2023: PloS One
https://read.qxmd.com/read/37494942/bictegravir-emtricitabine-and-tenofovir-alafenamide-versus-dolutegravir-emtricitabine-and-tenofovir-disoproxil-fumarate-for-initial-treatment-of-hiv-1-and-hepatitis-b-coinfection-alliance-a-double-blind-multicentre-randomised-controlled-phase-3-non-inferiority
#9
JOURNAL ARTICLE
Anchalee Avihingsanon, Hongzhou Lu, Chee Loon Leong, Chien-Ching Hung, Ellen Koenig, Sasisopin Kiertiburanakul, Man-Po Lee, Khuanchai Supparatpinyo, Fujie Zhang, Sophia Rahman, Michelle L D'Antoni, Hongyuan Wang, Jason T Hindman, Hal Martin, Jared M Baeten, Taisheng Li
BACKGROUND: For most adults with HIV-1 and hepatitis B virus (HBV) coinfection, initial recommended treatment is a tenofovir-containing antiretroviral regimen, but no randomised studies have compared tenofovir disoproxil fumarate with tenofovir alafenamide. We aimed to investigate whether bictegravir, emtricitabine, and tenofovir alafenamide is non-inferior to dolutegravir, emtricitabine, and tenofovir disoproxil fumarate for viral suppression in individuals with HIV-1 and HBV coinfection at 48 and 96 weeks...
October 2023: Lancet HIV
https://read.qxmd.com/read/37487131/erythematous-dermal-facial-plaques-in-a-neutropenic-patient
#10
JOURNAL ARTICLE
Erica J Mark, Corina A Rusu, Seth M Martin, Sarah Gradecki, R Hal Flowers
No abstract text is available yet for this article.
June 2023: Cutis; Cutaneous Medicine for the Practitioner
https://read.qxmd.com/read/37467975/recoupling-livestock-and-feed-production-in-the-netherlands-to-reduce-environmental-impacts
#11
JOURNAL ARTICLE
Benjamin van Selm, Renske Hijbeek, Martin K van Ittersum, Ollie van Hal, Corina E van Middelaar, Imke J M de Boer
In many places on earth, livestock and feed production are decoupled, as feed is grown in one region and fed to livestock in another. This disrupts nutrient cycles by depleting resources in feed producing regions and accumulating resources in livestock areas, which leads to environmental degradation. One solution is to recouple livestock and feed production at a more local level, which enhances nutrient circularity. Recoupling livestock and feed production creates a natural ceiling for livestock numbers based on the feed producing capacity of a region...
July 17, 2023: Science of the Total Environment
https://read.qxmd.com/read/37200995/bictegravir-emtricitabine-tenofovir-alafenamide-as-initial-treatment-for-hiv-1-five-year-follow-up-from-two-randomized-trials
#12
JOURNAL ARTICLE
Paul E Sax, José R Arribas, Chloe Orkin, Adriano Lazzarin, Anton Pozniak, Edwin DeJesus, Franco Maggiolo, Hans-Jürgen Stellbrink, Yazdan Yazdanpanah, Rima Acosta, Hailin Huang, Jason T Hindman, Hal Martin, Jared M Baeten, David Wohl
BACKGROUND: Bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) is a single-tablet regimen recommended for HIV-1 treatment. The safety and efficacy of B/F/TAF as initial therapy was established in two Phase 3 studies: 1489 (vs dolutegravir [DTG]/abacavir/lamivudine) and 1490 (vs DTG + F/TAF). After 144 weeks of randomized follow-up, an open-label extension evaluated B/F/TAF to 240 weeks. METHODS: Of 634 participants randomized to B/F/TAF, 519 completed the double-blinded treatment, and 506/634 (80%) chose the 96-week open-label B/F/TAF extension, which was completed by 444/506 (88%) participants...
May 2023: EClinicalMedicine
https://read.qxmd.com/read/37155933/effect-of-life-review-therapy-for-holocaust-survivors-a-randomized-controlled-trial
#13
JOURNAL ARTICLE
Simon Forstmeier, Sarah Zimmermann, Elisheva van der Hal, Martin Auerbach, Kristian Kleinke, Andreas Maercker, Danny Brom
Despite the therapeutic needs of aging Holocaust survivors, no randomized controlled trial (RCT) of psychotherapy exists for this population, with very few on older adults in general. This RCT aimed to compare the efficacy of Life Review Therapy for Holocaust survivors (LRT-HS) relative to a supportive control group. Holocaust survivors with a probable diagnosis of full or subsyndromal posttraumatic stress disorder (PTSD) or depressive disorder were included. Exclusion criteria were probable dementia, acute psychotic disorder, and acute suicidality...
May 8, 2023: Journal of Traumatic Stress
https://read.qxmd.com/read/37091761/imaging-changes-following-surgery-for-ischiofemoral-impingement
#14
JOURNAL ARTICLE
Munif Hatem, Richard Feng, Jordan Teel, Hal David Martin
Partial resection of the lesser trochanter (LT plasty) has been increasingly recommended to treat ischiofemoral impingement. However, there is a lack of studies on the imaging findings following LT plasty. The purpose of this study was to assess magnetic resonance imaging (MRI) changes on the lesser trochanter and surrounding musculotendinous structures following LT plasty to treat ischiofemoral impingement. Twenty-one patients (21 hips) were studied. The LT length and cross-sectional area of the iliopsoas muscle were measured on MRI before and after surgery...
2023: Proceedings of the Baylor University Medical Center
https://read.qxmd.com/read/37083596/feasibility-safety-and-functional-outcomes-using-the-neurological-controlled-hybrid-assistive-limb-exoskeleton-hal%C3%A2-following-acute-incomplete-and-complete-spinal-cord-injury%C3%A2-results-of-50-patients
#15
JOURNAL ARTICLE
Mirko Aach, Thomas Armin Schildhauer, Amrei Zieriacks, Oliver Jansen, Martin Weßling, Alexis Brinkemper, Dennis Grasmücke
OBJECTIVE: Recent studies reveal that Hybrid Assistive Limb (HAL®) locomotion training in paraplegic patients suffering from chronic spinal cord injury (SCI) induces improvements in functional and ambulatory mobility. The purpose of this study was to determine the safety, feasibility, and functional effectiveness of HAL® locomotion training in the initial rehabilitation of acute SCI patients. This clinical trial represents the first systematic intervention worldwide for acute SCI patients using a neurologically controlled exoskeleton...
July 2023: Journal of Spinal Cord Medicine
https://read.qxmd.com/read/37064579/isolating-neurologic-deficits-in-cervical-spondylotic-myelopathy-a-case-controlled-study-using-the-nih-toolbox-motor-battery
#16
JOURNAL ARTICLE
Fauziyya Muhammad, Alaa Baha, Grace Haynes, Hakeem Shakir, Michael Omini, Michael Martin, Kenneth A Weber, Monica Paliwal, Michael Van Hal, Douglas Dickson, Yasin Dhaher, Yan Daniel Zhao, Zachary A Smith
BACKGROUND AND OBJECTIVES: Patients with cervical spondylotic myelopathy (CSM) have motor impairments, including weakness, imbalance, and loss of dexterity. The reliable assessment of these symptoms is critical for treatment decisions. This study aimed to determine, for the first time, the use of the NIH Toolbox motor battery (NIHTBm) in the objective assessment of motor deficits in patients with CSM. METHODS: Patients with symptoms and MRI evidence of CSM and age-matched healthy controls (HC), with no evidence of spinal disorder or surgery were included in this case-control study based on our inclusion and exclusion criteria...
April 2023: Neurology. Clinical Practice
https://read.qxmd.com/read/36941387/-treatment-of-chronic-rhinosinusitis-with-nasal-polyps-crswnp-with-monoclonal-antibodies-biologics-s2k%C3%A2-guideline-of-the-german-society-of-oto-rhino-laryngology-head-and-neck-surgery-dghno-khc-and-the-german-college-of-general-practitioners-and-family-physicians
#17
REVIEW
Oliver Pfaar, Achim Georg Beule, Martin Laudien, Boris A Stuck
Monoclonal antibodies (so-called biologics) can be prescribed for chronic rhinosinusitis with nasal polyps (CRSwNP) within the scope of their market authorization. However, their prescription is limited to severe CRSwNP without disease control, whereby certain requirements must be met. Dupilumab, omalizumab, and mepolizumab have currently gained market authorization, with adequate evidence for their efficacy and safety available in the literature. It can be assumed that other biologics will be approved for this indication in the future...
March 20, 2023: HNO
https://read.qxmd.com/read/36919514/priming-effects-of-a-slot-machine-game-and-amphetamine-on-probabilistic-risk-taking-in-people-with-gambling-disorder-and-healthy-controls
#18
JOURNAL ARTICLE
Martin Zack, Daniela Lobo, Candice Biback, Tim Fang, Kelly Smart, Daniel Tatone, Aditi Kalia, Daniel Digiacomo, James L Kennedy
INTRODUCTION: The Game of Dice Task (GDT) captures probabilistic risk-taking, which is an important feature of addictions and integral to gambling disorder (GD). No research appears to have assessed effects of gambling-specific priming manipulations or the pharmacological basis of such effects on the GDT. AIMS: To investigate effects of slot machine gambling (Slots) and d-amphetamine (AMPH; 20 mg) on risk-taking in people with GD and healthy controls (HCs) (n = 30/group)...
February 2023: Journal of Clinical and Experimental Neuropsychology
https://read.qxmd.com/read/36912172/efficacy-and-safety-of-switching-to-bictegravir-emtricitabine-and-tenofovir-alafenamide-in-virologically-suppressed-asian-adults-living-with-hiv-a-pooled-analysis-from-three-international-phase-iii-randomized-trials
#19
JOURNAL ARTICLE
Anchalee Avihingsanon, Ploenchan Chetchotisakd, Sasisopin Kiertiburanakul, Winai Ratanasuwan, Krittaecho Siripassorn, Khuanchai Supparatpinyo, Hal Martin, Hui Wang, TinHung Wong, Hsiu Yin Wang
OBJECTIVES: Data on switching to bictegravir, emtricitabine, and tenofovir alafenamide (B/F/TAF) in virologically suppressed Asian people living with HIV are limited. We performed a pooled analysis of virologically suppressed Asian participants from three international phase III trials to evaluate the efficacy and safety of switching to B/F/TAF. METHODS: Virologically suppressed people living with HIV were randomized to switch to B/F/TAF or to stay on baseline regimens...
March 2023: HIV Medicine
https://read.qxmd.com/read/36866321/anterior-electronic-hip-pain-drawings-are-helpful-for-diagnosis-of-intra-articular-sources-of-pain-lateral-or-posterior-drawings-are-unreliable
#20
JOURNAL ARTICLE
Richard Feng, Munif Hatem, Hal David Martin
PURPOSE: The purpose of this study was to determine the accuracy of electronic hip pain drawing to diagnose intra-articular source of pain in nonarthritic hips, defined by response to an intra-articular injection. METHODS: A retrospective assessment was performed in consecutive patients who had an intra-articular injection completed within a 1-year period. Patients were classified as responders or nonresponders to intra-articular hip injection. A positive injection was defined as greater than 50% hip pain relief within 2 hours after injection...
February 2023: Arthroscopy, sports medicine, and rehabilitation
keyword
keyword
66603
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.